FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SAFIMESTOMIG
异名/同义词6MW3211
IMMUNOGLOBULIN G4 (232-PROLINE,360-LYSINE,439-ARGININE), BISPECIFIC, ANTI-(HUMAN CD47 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL 6MW3211 .GAMMA.4-CHAIN), (230->228'),(233->225')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G4 (227-PROLINE,438-GLUTAMIC ACID) ANTI-(HUMAN PROGRAMMED DEATH-LIGAND PD-L1) (HUMAN-MUS MUSCULUS MONOCLONAL 6MW3211 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 6MW3211 .KAPPA.-CHAIN
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CD47 (CD47 MOLECULE, INTEGRIN ASSOCIATED PROTEIN, IAP, MER6, OA3)) AND ANTI-(HOMO SAPIENS CD274 (PROGRAMMED CELL DEATH 1 LIGAND 1, PDL1, PD-L1, B7 HOMOLOG 1, B7H1, B7-H1, PDCD1LG1)), HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT
SAFIMESTOMIG
SAFIMESTOMIG [INN]
CAS登记号2911590-72-0
物质唯一标识(Unique Ingredient Identifier)LFQ9PP64F2
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System